Shobhit Sharma

Shobhit Sharma

Active Director Director DIN 06787070
DIN 06787070 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value •••• Premium profile

About Shobhit Sharma

Data last updated:

Shobhit Sharma is a Director at Teblik Drugs Private Limited (since 2014). The company operates in Pharma. Teblik Drugs Private Limited reported revenue of ₹3.05 Cr (FY 2025).

DIN 06787070
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2014
Oldest Company Age 37 yrs
Largest company Teblik Drugs Private Limited · ₹3.05 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Teblik Drugs Private Limited U24232MP1989PTC005061
Director28 Mar 20141989₹3.05 Cr (FY 2025)Active

Board colleagues of Shobhit Sharma

Directorship timeline

Open interactive timeline →
Teblik Drugs Private Limited
Premium access

Shareholding and investment profile for Shobhit Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shobhit Sharma

Shobhit Sharma currently holds 1 directorship: Teblik Drugs Private Limited (Director, since 28 Mar 2014, revenue ₹3.05 Cr (FY 2025)).

Shobhit Sharma was first appointed on 28 Mar 2014 as Director at Teblik Drugs Private Limited.

The current boards of Shobhit Sharma's companies include Renu Sharma (Teblik Drugs Private Limited), Soham Prakash Sharma (Teblik Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available